{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:08:58Z","timestamp":1791493738000,"version":"4.3.4"},"reference-count":40,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T00:00:00Z","timestamp":1400112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the effectiveness of enzyme replacement therapy (ERT) for adults and children with Fabry disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cohort study including prospective and retrospective clinical data. Age\u2010 and gender\u2010adjusted treatment effects were estimated using generalised linear mixed models. Treated patients contributed data before and during treatment and untreated patients contributed natural history data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Consenting adults (N\u2009=\u2009289) and children (N\u2009=\u200922) with a confirmed diagnosis of Fabry disease attending a specialist Lysosomal Storage Disorder treatment centre in England. At recruitment 211 adults and seven children were on ERT (range of treatment duration, 0 to 9.7 and 0 to 4.2 years respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>Clinical outcomes chosen to reflect disease progression included left ventricular mass index (LVMI); proteinuria; estimated glomerular filtration rate (eGFR); pain; hearing and transient ischaemic attacks (TIA)\/stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found evidence of a statistically significant association between time on ERT and a small linear decrease in LVMI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01); a reduction in the risk of proteinuria after adjusting for angiotensin\u2010converting enzyme inhibitors and angiotensin receptor blockers (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and a small increase in eGFR in men and women without pre\u2010treatment proteinuria (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 respectively). The same analyses in children provided no statistically significant results. No associations between time on ERT and pain, risk of needing a hearing aid, or risk of stroke or TIAs, were found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These data provide some further evidence on the long\u2010term effectiveness of ERT in adults with Fabry disease, but evidence of effectiveness could not be demonstrated in children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10545-014-9717-4","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T10:26:20Z","timestamp":1400063180000},"page":"969-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Long\u2010term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS\u2010LSD cohort study"],"prefix":"10.1002","volume":"37","author":[{"given":"L. J.","family":"Anderson","sequence":"first","affiliation":[{"name":"Institute of Health Research University of Exeter Medical School Veysey Building, Salmon Pool Lane Exeter Devon EX2 4SG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Wyatt","sequence":"additional","affiliation":[{"name":"Institute of Health Research University of Exeter Medical School Veysey Building, Salmon Pool Lane Exeter Devon EX2 4SG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Henley","sequence":"additional","affiliation":[{"name":"Institute of Health Research University of Exeter Medical School Veysey Building, Salmon Pool Lane Exeter Devon EX2 4SG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Nikolaou","sequence":"additional","affiliation":[{"name":"Institute of Health Research University of Exeter Medical School Veysey Building, Salmon Pool Lane Exeter Devon EX2 4SG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Waldek","sequence":"additional","affiliation":[{"name":"Independent Medical Consultant, Retired Metabolic Physician Formerly of Salford Royal NHS Foundation Trust Salford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Haematology, Royal Free Campus University College London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Pastores","sequence":"additional","affiliation":[{"name":"Department of Medicine\/National Centre for Inherited Metabolic Disorders Mater Misericordiae University Hospital Eccles Street Dublin 7 Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Logan","sequence":"additional","affiliation":[{"name":"Institute of Health Research University of Exeter Medical School Veysey Building, Salmon Pool Lane Exeter Devon EX2 4SG UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,15]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1415-47572012000600009"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-2-200701160-00148"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01424.x"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta10200"},{"key":"e_1_2_13_6_1","first-page":"317","article-title":"Fabry disease: clinical features and recent advances in enzyme replacement therapy","volume":"31","author":"Desnick RJ","year":"2001","journal-title":"Adv Nephrol Necker Hosp"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90771-X"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006663.pub3"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/318809"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080816"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000009948.86528.72"},{"key":"e_1_2_13_12_1","doi-asserted-by":"crossref","unstructured":"HenleyW AndersonLJ WyattKM NikolaouV AndersonR LoganS(2014)The NCS\u2010LSD cohort study: a description of the methods and analyses used to assess the long\u2010term effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with lysosomal storage disorders.JIMD Rep(in press)","DOI":"10.1007\/s10545-014-9679-6"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200410000-00020"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318074c986"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.104026"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euje.2005.12.014"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb02106.x"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01309.x"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61493-8"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-2-4"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.05.011"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-47"},{"key":"e_1_2_13_24_1","doi-asserted-by":"crossref","unstructured":"RombachSM SmidBE LinthorstGE DijkgraafMG HollakCE(2014)Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta\u2010analysis : Effectiveness of ERT in different disease stages.J Inherit Metab Dis(in press)","DOI":"10.1007\/s10545-014-9677-8"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9327"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp031"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.11.007"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008030287"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.526293"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra054415"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012030316"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000598"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04340510"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr420"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.794529"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12077"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/422366"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2007.09.013"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.09.007"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta16390"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-014-9717-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T02:30:38Z","timestamp":1694745038000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-014-9717-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,15]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1007\/s10545-014-9717-4"],"URL":"https:\/\/doi.org\/10.1007\/s10545-014-9717-4","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,15]]}}}